1
Louis A Errede, James D Stoesz, George D Winter deceased: Composite wound dressing. Minnesota Mining and Manufacturing Company, Cruzan Alexander, Donald M Sell, Lorraine R Sherman, February 15, 1983: US04373519 (622 worldwide citation)

A composite wound dressing, optionally having controlled permeability, is highly absorbent toward blood and exudate and comprises a polytetrafluoroethylene fibril matrix, hydrophilic absorptive particles enmeshed in the matrix, and, optionally, a partially occlusive film coated on one surface of the ...


2
Louis A Errede, James D Stoesz, Jenny Upton: Water-swellable composite sheet of microfibers of PTFE and hydrophilic absorptive particles. Minnesota Mining and Manufacturing Company, Donald M Sell, James A Smith, Lorraine R Sherman, July 17, 1984: US04460642 (163 worldwide citation)

A composite sheet material is highly absorbent toward aqueous fluids including blood and exudate and comprises a polytetrafluoroethylene fibril matrix and hydrophilic absorptive particles enmeshed in the matrix. The composite sheet material is useful as a wound dressing, as a drying material for non ...


3
Louis A Errede, James D Stoesz, George D Winter deceased: Method for making water-swellable composite sheet. Minnesota Mining and Manufacturing Company, Donald M Sell, James A Smith, Lorraine R Sherman, January 21, 1986: US04565663 (61 worldwide citation)

A method of preparing a tear-resistant composite sheet material having hydrophilic, absorptive particles enmeshed in a network of interlaced microfibrous polytetrafluoroethylene forming a fibril matrix, the hydrophilic absorptive particles having absorptive particles with absorptive capacity greater ...


4
James D Stoesz, Alexis S Statham, Myhanh T Truong: Immune response modifier compositions and methods. 3M Innovative Properties Company, Edwards Wildman Palmer, Peter J Manso, Kathryn A Piffat, February 28, 2012: US08124096

A pharmaceutical composition comprising 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine that is stable to sterilization and suitable for topical application directly to tissue sites where the dermis has been breached, and has been sterilized, packaged compositions that have been sterilized, and ...


5
Richard L Miller, Mark A Tomai, Ross M Kedl, Isidro Angelo Eleazar Zarraga, Ronnie Ortiz, James D Stoesz: Methods and compositions for enhancing immune response. December 30, 2004: US20040265351-A1

Methods and compositions for enhancing the immune response to an IRM compound by depositing within a localized tissue region an IRM depot preparation that provides an extended residence time of active IRM within the localized tissue region.


6
James D Stoesz, Cynthia A Guy: Immune Response Modifier Formulations And Methods. Coley Pharmaceutical Group, Wolf Greenfield & Sacks PC, August 28, 2008: US20080207674-A1

An aqueous parenteral pharmaceutical formulation of the IRM drug compound N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide dissolved in water, buffer selected from citric acid, acetic acid, lactic acid, succinic acid, and tartaric acid, and optionally a tonicity adjuster ...


7
James D Stoesz, Cynthia A Guy: Immune response modifier formulations and methods. Wolf Greenfield & Sacks PC, January 27, 2011: US20110021554-A1

An aqueous parenteral pharmaceutical formulation of the IRM drug compound N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide dissolved in water, buffer selected from citric acid, acetic acid, lactic acid, succinic acid, and tartaric acid, and optionally a tonicity adjuster ...


8
Kevin S Gorski, Ronnie Ortiz, James D Stoesz, Isidro Angelo E Zarraga: Formulation for delivery of immune response modifiers. 3m Innovative Properties Company, 3m Innovative Properties Company, February 4, 2010: US20100028381-A1

The present invention provides pharmaceutical compositions that include an IRM-PEG complex and an antigen, formulated together in a thermoresponsive gel. In another aspect, the present invention also provides a method of eliciting an antigen-specific immune response in a subject. Generally, the meth ...


9
James D Stoesz, Alexis S Statham, Myhanh T Troung: Immune Response Modifier Compositions and Methods. Edwards Angell Palmer & Dodge, April 22, 2010: US20100096287-A1

A pharmaceutical composition comprising 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine that is stable to sterilization and suitable for topical application directly to tissue sites where the dermis has been breached, and has been sterilized, packaged compositions that have been sterilized, and ...



Click the thumbnails below to visualize the patent trend.